Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 883,500 | 767,700 | 739,400 | 759,300 | 697,300 |
| Cost of Goods | 215,600 | 213,200 | 201,400 | 202,500 | 180,300 |
| Gross Profit | 667,900 | 554,500 | 538,000 | 556,800 | 517,000 |
| Operating Expenses | 360,000 | 383,200 | 343,100 | 342,200 | 315,400 |
| Operating Income | 308,500 | 171,500 | 195,300 | 215,100 | 201,900 |
| Interest Expense | 2,400 | 12,300 | 2,100 | 2,400 | 2,400 |
| Other Income | -12,500 | 41,200 | -8,000 | -43,700 | -16,200 |
| Pre-tax Income | 293,600 | 200,400 | 185,200 | 169,000 | 183,300 |
| Income Tax | 63,400 | 41,900 | 43,800 | 42,400 | 40,300 |
| Net Income Continuous | 230,200 | 158,500 | 141,400 | 126,600 | 143,000 |
| Net Income | $230,200 | $158,500 | $141,400 | $126,600 | $143,000 |
| EPS Basic Total Ops | 0.36 | 0.25 | 0.22 | 0.20 | 0.22 |
| EPS Basic Continuous Ops | 0.36 | 0.25 | 0.22 | 0.20 | 0.22 |
| EPS Diluted Total Ops | 0.35 | 0.24 | 0.22 | 0.19 | 0.22 |
| EPS Diluted Continuous Ops | 0.35 | 0.24 | 0.22 | 0.19 | 0.22 |
| EBITDA(a) | $329,600 | $190,600 | $213,500 | $233,100 | $217,800 |